4 days Where Will AbbVie Be in 5 Years?Yahoo Finance

Where Will AbbVie Be in 5 Years?.

AbbVie (ABBV)

12 hours AbbVie: Upgrading To ‘Strong Buy’ After PullbackSeeking Alpha X

14 hours Trade Tracker: Jim Lebenthal buys more AbbvieYouTube X

16 hours AbbVie Jumps 5% On An Upgrade Despite Bristol Myers-Tied SetbackInvestor's Business Daily X

17 hours AbbVie, Nvidia Lead Friday’s Market Cap Stock MoversInvesting.com X

3 days Is Trending Stock AbbVie Inc. (ABBV) a Buy Now?Zacks X

4 days Where Will AbbVie Be in 5 Years?The Motley Fool X

5 days AbbVie’s Ovarian Cancer Drug Elahere Gets Approval in EuropeZacks X

5 days Why This Beaten-Down Dividend Stock Is a No-Brainer Buy on the DipThe Motley Fool X

7 days Dividend King AbbVie Just Paid Investors: Here’s How Much They Got24/7 Wall St. X

1 week Pharma Stock Roundup: AZN, BAYRY’s Earnings, ABBV’s Pipeline SetbackZacks X

1 week AbbVie Stock Falls 11% in a Month: Should You Buy the Dip?Zacks X

1 week Got $1,500 to Invest? AbbVie Just Proved the Bull Thesis for Its StockThe Motley Fool X

1 week Final Trades: Bitcoin, Abbvie and Baker HughesYouTube X

1 week Aldeyra’s FDA Resubmission And AbbVie Option Revitalize Reproxalap’s ProspectsSeeking Alpha X

2 weeks AbbVie’s Schizophrenia Failure Disappoints But Analysts Show Confidence In Immunology PortfolioYahoo Finance X

2 weeks Final Trades: Lyft, Meta, United States Oil Fund & AbbvieYouTube X

2 weeks AbbVie And Pfizer: Q3 Dividend Checkup Post-EarningsSeeking Alpha X

2 weeks Is AbbVie Still A Strong Buy After Fantastic Gains? (Rating Downgrade)Seeking Alpha X

2 weeks AbbVie Stock: Keep Calm And Buy The DipSeeking Alpha X

2 weeks Why AbbVie Stock Was Getting Mashed on MondayThe Motley Fool X

2 weeks Bristol Rockets 11% As Investors Question AbbVie’s $8.7 Billion ‘Mistake’Investor's Business Daily X

2 weeks AbbVie Tumbles After New Schizophrenia Drug Fails Two TrialsYahoo Finance X

2 weeks RHHBY or ABBV: Which Is the Better Value Stock Right Now?Zacks X

3 weeks Analyst Report: AbbVie IncYahoo Finance X

3 weeks Market Digest: THRM, DINO, KLAC, OKE, RJF, SYK, META, ABBV, NCLHYahoo Finance X

3 weeks Pharma Stock Roundup: MRK, PFE, ABBV, NVS, LLY’s Q3 Earnings in FocusZacks X

3 weeks AbbVie (NYSE:ABBV) Releases Quarterly Earnings Results, Beats Estimates By $0.08 EPSMarketBeat X

3 weeks AbbVie: 3 Positives From The Earnings ReportSeeking Alpha X

3 weeks AbbVie Inc. (NYSE:ABBV) Short Interest Up 8.9% in OctoberMarketBeat X

3 weeks AbbVie (ABBV) Q3 2024 Earnings Call TranscriptThe Motley Fool X

3 weeks AbbVie Trumps Q3 Earnings & Sales Estimates, Raises ’24 EPS ViewZacks X

3 weeks AbbVie (NYSE:ABBV) Stock Price Up 3.2% After Dividend AnnouncementMarketBeat X

3 weeks Compared to Estimates, AbbVie (ABBV) Q3 Earnings: A Look at Key MetricsZacks X

3 weeks AbbVie raises 2024 profit forecast on strong sales of key drugs Skyrizi, RinvoqInvesting.com X

3 weeks AbbVie Has A New Cash Cow As Humira Bows To Skyrizi In Third-Quarter BeatInvestor's Business Daily X

4 weeks Will These 5 Big Drug Stocks Surpass Q3 Earnings Forecasts?Zacks X

4 weeks AbbVie (NYSE:ABBV) Shares Up 1.1% After Analyst UpgradeMarketBeat X

4 weeks First American Bank Cuts Stake in AbbVie Inc. (NYSE:ABBV)MarketBeat X

4 weeks Hamlin Capital Management LLC Buys 76,218 Shares of AbbVie Inc. (NYSE:ABBV)MarketBeat X

4 weeks Mediolanum International Funds Ltd Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

4 weeks Final Trades: Tesla, Sweetgreen, AbbVie and Digital RealtyYouTube X

4 weeks AbbVie (ABBV) Outperforms Broader Market: What You Need to KnowZacks X

4 weeks AbbVie (NYSE:ABBV) Stock Price Up 1% – What’s Next?MarketBeat X

1 month Private Advisor Group LLC Reduces Stock Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

1 month Beat the Nasdaq With This Cash-Gushing Dividend StockThe Motley Fool X

1 month AbbVie (NYSE:ABBV) Stock Price Down 0% – Here’s What HappenedMarketBeat X

1 month Foundations Investment Advisors LLC Has $12.81 Million Position in AbbVie Inc. (NYSE:ABBV)MarketBeat X

1 month AbbVie: Strong Dividends But Humira DisappointsSeeking Alpha X

1 month The Zacks Analyst Blog Highlights Johnson & Johnson, Pfizer, Roche, AbbVie and SanofiZacks X

1 month AbbVie (NYSE:ABBV) Shares Down 0.5% – Time to Sell?MarketBeat X